Matches in DBpedia 2015-10 for { ?s ?p "Nicholas B. Lydon FRS (born 27 February 1957) is a British scientist and entrepreneur. In 2009 he was awarded the Lasker Clinical Award and in 2012 the Japan Prize for the development of Gleevec, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia (CML), which converted a fatal cancer into a manageable chronic condition."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Nicholas_Lydon abstract "Nicholas B. Lydon FRS (born 27 February 1957) is a British scientist and entrepreneur. In 2009 he was awarded the Lasker Clinical Award and in 2012 the Japan Prize for the development of Gleevec, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia (CML), which converted a fatal cancer into a manageable chronic condition.".
- Nicholas_Lydon comment "Nicholas B. Lydon FRS (born 27 February 1957) is a British scientist and entrepreneur. In 2009 he was awarded the Lasker Clinical Award and in 2012 the Japan Prize for the development of Gleevec, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia (CML), which converted a fatal cancer into a manageable chronic condition.".